Rheumatic diseases and autoimmune vascular dementia.

Vascular dementia (VD) comes second after Alzheimer's disease (AD) as a cause of impaired cognition. VD is not a specific nosological entity, but rather a syndrome encompassing a number of diseases caused by impaired supply of blood to the brain. Systemic autoimmune disorders such as systemic lupus erythematosus, rheumatoid arthritis, vasculitis and antiphospholipid syndrome (APS) can be associated with dementia. VD is often related to the presence of traditional cardiovascular risk factors, but it may also be associated with a host of disorders affecting the brain blood vessels, neuronal cells, or both. It is important to entertain in the differential diagnosis of VD, to recognize and to cure them accurately in order to preserve life's quality of our patients.

• Publication year

  2017

• Venue

  Autoimmunity Reviews

• Publication date

  2017-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.autrev.2017.10.011PMID 29037904
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased Risk of Dementia in Patients With Systemic Lupus Erythematosus: A Nationwide Population‐Based Cohort Study

  2016cited by this paper
• Rheumatoid arthritis and the risk of dementia: A systematic review and meta-analysis.

  2016cited by this paper
• Current treatment of antiphospholipid syndrome: lights and shadows

  2015cited by this paper
• Mice with experimental antiphospholipid syndrome display hippocampal dysfunction and a reduction of dendritic complexity in hippocampal CA1 neurones

  2015cited by this paper
• Blood-brain barrier impairment in dementia: current and future in vivo assessments.

  2015cited by this paper
• Tocilizumab for severe refractory neuro-Behçet: three cases IL-6 blockade in neuro-Behçet.

  2015cited by this paper
• Vascular dementia.

  2015cited by this paper
• The incidence of giant cell arteritis in Olmsted County, Minnesota, over a 60-year period 1950–2009

  2015cited by this paper
• A novel pathway of cellular activation mediated by antiphospholipid antibody‐induced extracellular vesicles

  2015cited by this paper
• Anti-NR2A/B Antibodies and Other Major Molecular Mechanisms in the Pathogenesis of Cognitive Dysfunction in Systemic Lupus Erythematosus

  2015cited by this paper
• Altered receptor binding densities in experimental antiphospholipid syndrome despite only moderately enhanced autoantibody levels and absence of behavioral features.

  2014cited by this paper
• IgG accumulates in inhibitory hippocampal neurons of experimental antiphospholipid syndrome.

  2014cited by this paper
• Risk of Stroke in Patients with Rheumatism: A Nationwide Longitudinal Population-based Study

  2014cited by this paper
• Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers

  2014cited by this paper
• Neurological impairment in experimental antiphospholipid syndrome is associated with increased ligand binding to hippocampal and cortical serotonergic 5-HT1A receptors.

  2013cited by this paper
• Central nervous system involvement in systemic lupus erythematosus: Overview on classification criteria.

  2013cited by this paper
• The pathogenesis of the antiphospholipid syndrome.

  2013cited by this paper
• The pathobiology of vascular dementia.

  2013cited by this paper
• Coagulopathy triggered autoimmunity: experimental antiphospholipid syndrome in factor V Leiden mice

  2013cited by this paper
• Elevated BAFF Levels in the Cerebrospinal Fluid of Patients with Neuro-Behçet's Disease: BAFF is Correlated with Progressive Dementia and Psychosis

  2012cited by this paper
• Significant Changes in the Levels of Secreted Cytokines in Brains of Experimental Antiphospholipid Syndrome Mice

  2012cited by this paper
• Adult primary central nervous system vasculitis.

  2012cited by this paper
• Autoimmune and inflammatory mechanisms of CNS damage.

  2011cited by this paper
• Anatomical localization of protease‐activated receptor‐1 and protease‐mediated neuroglilal crosstalk on peri‐synaptic astrocytic endfeet

  2011cited by this paper
• Non-psychiatric comorbidity associated with Alzheimer's disease.

  2011cited by this paper
• Anti-annexin II antibody is associated with thrombosis and/or pregnancy morbidity in antiphospholipid syndrome and systemic lupus erythematosus with thrombosis

  2011cited by this paper
• Rapidly progressive dementia due to leukocytoclastic vasculitis of the central nervous system

  2011cited by this paper
• Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis involving the central nervous system: case report and review of the literature.

  2010cited by this paper
• EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

  2010cited by this paper
• Cerebral Vasculitis Associated With Amyloid Angiopathy

  2010cited by this paper
• Cerebral vasculitis associated with amyloid angiopathy: case report.

  2010cited by this paper
• The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe

  2009cited by this paper
• Prospective Study of Neuropsychiatric Events in Systemic Lupus Erythematosus

  2009cited by this paper
• Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study.

  2009cited by this paper
• Primary CNS vasculitis with spinal cord involvement

  2008cited by this paper
• Stroke and multi-infarct dementia as presenting symptoms of giant cell arteritis: report of 7 cases and review of the literature.

  2008cited by this paper
• Angiography-Negative Primary Central Nervous System Vasculitis: A Syndrome Involving Small Cerebral Vessels

  2008cited by this paper
• Anti-annexin II Antibodies in Systemic Autoimmune Diseases and Antiphospholipid Syndrome

  2008cited by this paper
• Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy.

  2008cited by this paper
• Thrombin receptor PAR-1 on myelin at the node of Ranvier: a new anatomy and physiology of conduction block.

  2008cited by this paper
• Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus

  2007cited by this paper
• Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV)

  2007cited by this paper
• Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study.

  2007cited by this paper
• Cerebral vasculitis in a patient with rheumatoid arthritis.

  2007cited by this paper
• Central nervous system involvement as a major manifestation of rheumatoid arthritis

  2007cited by this paper
• Primary central nervous system vasculitis: analysis of 101 patients

  2007cited by this paper
• Giant cell arteritis: Involvement of intracranial arteries.

  2006cited by this paper
• Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies.

  2005cited by this paper
• Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome.

  2005cited by this paper
• Antiphospholipid antibodies, thrombin and LPS activate brain endothelial cells and Ras-dependent pathways through distinct mechanisms.

  2005cited by this paper
• Central nervous system manifestations of rheumatologic diseases

  2005cited by this paper
• Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients.

  2005cited by this paper
• Clinical manifestations of Behçet's disease in 137 Italian patients: results of a multicenter study.

  2004cited by this paper
• Rapidly reversible dementia in cerebral amyloid inflammatory vasculopathy

  2004cited by this paper
• The antiphospholipid (Hughes') syndrome: changing the face of neurology.

  2004cited by this paper
• Frequency and patterns of subclinical cognitive impairment in patients with ANCA-associated small vessel vasculitides.

  2002cited by this paper
• Antiphospholipid Antibodies in the Acute Phase of Cerebral Ischaemia in Young Adults: A Descriptive Study of 139 Patients

  2002cited by this paper
• Spectrum of antiphospholipid antibodies (aPL) in patients with cerebrovascular disease.

  2001cited by this paper
• Dementia and Antiphospholipid Antibodies

  2000cited by this paper
• A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus.

  1999cited by this paper
• The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes.

  1999cited by this paper
• Psychological aspects of systemic lupus erythematosus: cognitive function, mood, and self-report.

  1997cited by this paper
• Polymyalgia rheumatica and giant cell arteritis.

  1995cited by this paper
• Cerebral vasculitis complicating rheumatoid arthritis.

  1995cited by this paper
• The Incidence of Giant Cell Arteritis in Olmsted County, Minnesota: Apparent Fluctuations in a Cyclic Pattern

  1995cited by this paper
• An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation.

  1994cited by this paper
• Blood brain barrier function in vascular dementia

  1990cited by this paper
• Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies.

  1987cited by this paper
• Polymyalgia rheumatica and giant-cell arteritis.

  1978cited by this paper
• International Journal of General Medicine Dovepress Multimodal Neurophysiological and Psychometric Evaluation among Patients with Systemic Lupus Erythematosus

  year unknowncited by this paper

• Temporal comorbidity patterns in Alzheimer's disease and vascular dementia: A population‐based observational study in UK Biobank

  2026cites this paper
• Cognitive disorders in patients with neuroimmunological disease

  2025cites this paper
• Uncovering multimorbidity patterns linked to disability in aging populations: A machine learning analysis

  2025cites this paper
• Chronological Mapping of Comorbidities in Alzheimer's Disease and Vascular Dementia

  2025cites this paper
• Brain-targeting autoantibodies in patients with dementia

  2024cites this paper
• Association of infertility and recurrent pregnancy loss with the risk of dementia

  2024cites this paper
• Novel insights into molecular signatures and pathogenic cell populations shared by systemic lupus erythematosus and vascular dementia

  2023cites this paper
• Melatonin and Aging.

  2023cites this paper
• Identification of potential drug targets for vascular dementia and carotid plaques by analyzing underlying molecular signatures shared by them

  2022cites this paper
• Inflammatory rheumatic diseases and the risk of Parkinson's disease: A systematic review and meta-analysis

  2022cites this paper
• Association between dementia and systemic rheumatic disease: A nationwide population-based study

  2021cites this paper
• Association of cardiovascular disease and traditional cardiovascular risk factors with the incidence of dementia among patients with rheumatoid arthritis.

  2021cites this paper
• [Mental disorders and cognitive impairment in patients with antiphospholipid syndrome].

  2020cites this paper
• Психические расстройства и когнитивные нарушения у больных антифосфолипидным синдромом

  2020cites this paper
• Melatonin and Regulation of Immune Function: Impact on Numerous Diseases.

  2020cites this paper
• Vascular Arginase Is a Relevant Target to Improve Cerebrovascular Endothelial Dysfunction in Rheumatoid Arthritis: Evidence from the Model of Adjuvant-Induced Arthritis

  2019cites this paper
• Dysfonction endothéliale au niveau de différents territoires vasculaires en cas de polyarthrite rhumatoïde : physiopathologie et perspectives thérapeutiques

  2019cites this paper
• Embelin Improves the Spatial Memory and Hippocampal Long-Term Potentiation in a Rat Model of Chronic Cerebral Hypoperfusion

  2019cites this paper
• Prevalence of affective disorders and dementia in inflammatory polyarthropathies

  2019cites this paper
• Effects of electroacupuncture of different frequencies on free radicals in hippocampus of mice with vascular dementia

  2018cites this paper
• Low Levels of Renin and High Aldosterone-to-Renin Ratio Among Rheumatoid Patients and Ankylosing Spondylitis Patients: A Prospective Study.

  2018cites this paper